Latest article
Healio: DARE-19: Dapagliflozin well-tolerated for inpatient COVID-19 with, with out diabetes
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...
